Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab

Br J Dermatol. 2021 May;184(5):e148. doi: 10.1111/bjd.19681. Epub 2020 Dec 4.

Authors

J Ricar¹, P Cetkovska¹

Affiliation

¹ Department of Dermatovenereology, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.

PMID: 33274752
DOI: 10.1111/bjd.19681

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal
Humans
Pityriasis Rubra Pilaris* / drug therapy

Substances

Antibodies, Monoclonal
risankizumab